CADL · Company research
Candel Therapeutics, Inc. (CADL): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
22records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Why CADL Stock Plunged Nearly 15% In After-Hours Trading Today - Stocktwits | Why CADL Stock Plunged Nearly 15% In After-Hours Trading Today Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| CADL Stock In Focus As Candel Nears Year-End BLA Filing For Prostate Cancer Drug — Eyes $10–$16B Opportunity - Stocktwits | CADL Stock In Focus As Candel Nears Year-End BLA Filing For Prostate Cancer Drug — Eyes $10–$16B Opportunity Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| CADL Rises As Biotech Eyes First Commercial Product in 2027 — CEO Points To ‘Meaningful Execution’ Toward BLA Submission In Q4 - Stocktwits | CADL Rises As Biotech Eyes First Commercial Product in 2027 — CEO Points To ‘Meaningful Execution’ Toward BLA Submission In Q4 Stocktwits | View source ↗ | Stocktwits | Oct 14, 2026 | neutral | 0 | 0.6 |
| CADL Stock On Track For Best Day In Nearly 16 Months — What’s Driving The Rally? - Stocktwits | CADL Stock On Track For Best Day In Nearly 16 Months — What’s Driving The Rally? Stocktwits | View source ↗ | Stocktwits | Oct 13, 2026 | neutral | 0 | 0.6 |
| Candel Therapeutics, Inc. (CADL) stock price, news, quote and history - Yahoo Finance Australia | Candel Therapeutics, Inc. (CADL) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 3, 2026 | neutral | 0 | 0.6 |
| A director receives 2,189 options instead of quarterly cash pay at Candel Therapeutics (CADL). - Stock Titan | A director receives 2,189 options instead of quarterly cash pay at Candel Therapeutics (CADL). Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Candel Therapeutics to Present at the SITC 2026 Annual Meeting | Candel Therapeutics announced that it will present data from its aglatimagene besadenovec program in non-small cell lung cancer and clinical findings from its phase 1b trial of linoserpaturev in recurrent glioblastoma at the Society for Immunotherapy of Cancer's 41st Annual Meeting in November 2026. The presentations will showcase multi-omics analyses revealing immune activation and improved survival outcomes. | View source ↗ | GlobeNewswire Inc. | Oct 2, 2026 | bullish | 1 | 1 |
| Candel Therapeutics to Present at the SITC 2026 Annual Meeting | Candel Therapeutics announced that it will present data from its aglatimagene besadenovec program in non-small cell lung cancer and clinical findings from its phase 1b trial of linoserpaturev in recurrent glioblastoma at the Society for Immunotherapy of Cancer's 41st Annual Meeting in November 2026. The presentations will showcase multi-omics analyses revealing immune activation and improved survival outcomes. | View source ↗ | GlobeNewswire Inc. | Oct 2, 2026 | bullish | 1 | 1 |
| Candel will present findings on lung cancer that progressed despite immunotherapy and recurrent brain cancer. - Stock Titan | Candel will present findings on lung cancer that progressed despite immunotherapy and recurrent brain cancer. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Candel Therapeutics NSCLC Trial: 24.5-Month Median Survival | CADL Stock News - Stock Titan | Candel Therapeutics NSCLC Trial: 24.5-Month Median Survival | CADL Stock News Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| CADL Slips Despite Encouraging Prostate Cancer Drug Data — Retail Believes Stock Is ‘Clearly A Buy And Hold’ - Yahoo Finance | CADL Slips Despite Encouraging Prostate Cancer Drug Data — Retail Believes Stock Is ‘Clearly A Buy And Hold’ Yahoo Finance | View source ↗ | Yahoo Finance | Sep 30, 2026 | neutral | 0 | 0.6 |
| Understanding Momentum Shifts in (CADL) - Stock Traders Daily | Understanding Momentum Shifts in (CADL) Stock Traders Daily | View source ↗ | Stock Traders Daily | Sep 26, 2026 | neutral | 0 | 0.6 |
| Candel Therapeutics: Strong Buy On Aglatimagene Prostate Cancer BLA Filing In Q4 (CADL) - Seeking Alpha | Candel Therapeutics: Strong Buy On Aglatimagene Prostate Cancer BLA Filing In Q4 (CADL) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 22, 2026 | neutral | 0 | 0.6 |
| Candel Therapeutics Shares Rise After BofA Upgrade - Yahoo Finance | Candel Therapeutics Shares Rise After BofA Upgrade Yahoo Finance | View source ↗ | Yahoo Finance | Sep 21, 2026 | neutral | 0 | 0.6 |
| $CADL stock is down 11% today. Here's what we see in our data. - Quiver Quantitative | $CADL stock is down 11% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 11, 2026 | neutral | 0 | 0.6 |
| Candel CEO to Join Three Investor Conference Webcasts in September - Stock Titan | Candel CEO to Join Three Investor Conference Webcasts in September Stock Titan | View source ↗ | Stock Titan | Aug 26, 2026 | neutral | 0 | 0.6 |
| Has Candel Therapeutics (CADL) Run Too Far Ahead On Widening Losses? - Simply Wall Street | Has Candel Therapeutics (CADL) Run Too Far Ahead On Widening Losses? Simply Wall Street | View source ↗ | Simply Wall Street | Aug 23, 2026 | neutral | 0 | 0.6 |
| Candel Therapeutics (CADL) Faces Bigger Losses As Its Valuation Still Looks Pricey - Yahoo Finance | Candel Therapeutics (CADL) Faces Bigger Losses As Its Valuation Still Looks Pricey Yahoo Finance | View source ↗ | Yahoo Finance | Aug 20, 2026 | neutral | 0 | 0.6 |
| Candel's Prostate Therapy Candidate Shows 39% Disease-Free Survival Improvement - Stock Titan | Candel's Prostate Therapy Candidate Shows 39% Disease-Free Survival Improvement Stock Titan | View source ↗ | Stock Titan | Aug 13, 2026 | neutral | 0 | 0.6 |
| This Small-Cap Biotech Is Having Its Best Week In A Month – Here’s What’s Driving It - Stocktwits | This Small-Cap Biotech Is Having Its Best Week In A Month – Here’s What’s Driving It Stocktwits | View source ↗ | Stocktwits | Jun 5, 2026 | neutral | 0 | 0.6 |
| CADL Stock Edges Up After Hours On Strong Extended Prostate Cancer Data - Stocktwits | CADL Stock Edges Up After Hours On Strong Extended Prostate Cancer Data Stocktwits | View source ↗ | Stocktwits | May 15, 2026 | neutral | 0 | 0.6 |
| $CADL stock is down 8% today. Here's what we see in our data. - Quiver Quantitative | $CADL stock is down 8% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Apr 24, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.